Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oncothyreon -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (2316)	10/13/2013 9:05:43 PM
From: Clarksterh	Respond to of 2344

I was warned by a close friend, and there's a guy at twitter/I.V. who also put it out there, clearly and with spotlight.... this company is very poorly managed. They were scrambling to in-license while talking up 866. Next came a presentation where 866 wasn't even discussed. Most obvious bait and switch I've ever witnessed/swallowed, just so tacky. Don't take this wrong - but even most of the long-time longs have acknowledged for years that the management of ONTY is piss poor. And spots rarely change without a change in leadership. FWIW.